Cumberland Pharmaceuticals Inc. Excess Tax Benefit from Share-based Compensation, Financing Activities
Cumberland Pharmaceuticals Inc. (CPIX) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-03-12
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-12-31 was $0.00.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-06-30 was $0.00.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-03-31 was $0.00.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2018 was $0.00.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2017 was $0.00.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was -$1.03M, a 1228.15% decline from fiscal 2015.
- Cumberland Pharmaceuticals Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $90.98K, a 94.50% decline from fiscal 2014.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $0.00 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | -$119.14K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | -$119.14K derived: sum of 3 quarters · filed 2019-03-12 | -$191.40K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | -$119.14K derived: sum of 2 quarters · filed 2019-03-12 | -$191.40K derived: sum of 3 quarters · filed 2019-03-12 | -$598.42K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$119.14K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$191.40K derived: sum of 2 quarters · filed 2019-03-12 | -$598.42K derived: sum of 3 quarters · filed 2019-03-12 | -$1.03M 10-K · filed 2019-03-12 |
| 2016-09-30 | -$72.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$479.28K derived: sum of 2 quarters · filed 2017-11-08 | -$907.27K 10-Q · filed 2017-11-08 | -$1.29M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | -$407.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$835.02K 10-Q · filed 2017-08-09 | -$1.21M derived: sum of 3 quarters · filed 2018-03-09 | -$1.06M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$427.99K 10-Q · filed 2017-05-15 | -$807.60K derived: sum of 2 quarters · filed 2018-03-09 | -$650.97K derived: sum of 3 quarters · filed 2018-03-09 | -$355.57K derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | -$379.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$222.97K derived: sum of 2 quarters · filed 2018-03-09 | $72.42K derived: sum of 3 quarters · filed 2018-03-09 | $90.98K 10-K · filed 2018-03-09 |
| 2015-09-30 | $156.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $452.03K derived: sum of 2 quarters · filed 2016-11-03 | $470.58K 10-Q · filed 2016-11-03 | $1.05M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $295.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $313.95K 10-Q · filed 2016-08-05 | $889.88K derived: sum of 3 quarters · filed 2017-03-13 | $1.26M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $18.56K 10-Q · filed 2016-05-13 | $594.49K derived: sum of 2 quarters · filed 2017-03-13 | $960.24K derived: sum of 3 quarters · filed 2017-03-13 | $1.48M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $575.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $941.68K derived: sum of 2 quarters · filed 2017-03-13 | $1.47M derived: sum of 3 quarters · filed 2017-03-13 | $1.65M 10-K · filed 2017-03-13 |
| 2014-09-30 | $365.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $889.09K derived: sum of 2 quarters · filed 2015-11-06 | $1.08M 10-Q · filed 2015-11-06 | $1.64M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $523.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $711.35K 10-Q · filed 2015-08-07 | $1.27M derived: sum of 3 quarters · filed 2016-03-14 | $744.08K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $188.01K 10-Q · filed 2015-05-15 | $747.94K derived: sum of 2 quarters · filed 2016-03-14 | $220.74K derived: sum of 3 quarters · filed 2016-03-14 | -$242.67K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $559.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $32.74K derived: sum of 2 quarters · filed 2016-03-14 | -$430.67K derived: sum of 3 quarters · filed 2016-03-14 | $48.02K 10-K · filed 2016-03-14 |
| 2013-09-30 | -$527.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$990.61K derived: sum of 2 quarters · filed 2014-11-07 | -$511.91K 10-Q · filed 2014-11-07 | $1.07M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | -$463.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $15.29K 10-Q · filed 2014-08-08 | $1.60M derived: sum of 3 quarters · filed 2015-03-09 | $2.92M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $478.70K 10-Q · filed 2014-05-12 | $2.06M derived: sum of 2 quarters · filed 2015-03-09 | $3.38M derived: sum of 3 quarters · filed 2015-03-09 | $4.05M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $2.91M derived: sum of 2 quarters · filed 2015-03-09 | $3.57M derived: sum of 3 quarters · filed 2015-03-09 | $3.76M 10-K · filed 2015-03-09 |
| 2012-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.99M derived: sum of 2 quarters · filed 2013-11-06 | $2.18M 10-Q · filed 2013-11-06 | $1.87M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $663.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $854.99K 10-Q · filed 2013-08-09 | $553.07K derived: sum of 3 quarters · filed 2014-03-11 | $1.69M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | $191.08K 10-Q · filed 2013-05-08 | -$110.83K derived: sum of 2 quarters · filed 2014-03-11 | $1.03M derived: sum of 3 quarters · filed 2014-03-11 | $2.41M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | -$301.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $838.78K derived: sum of 2 quarters · filed 2014-03-11 | $2.21M derived: sum of 3 quarters · filed 2014-03-11 | $2.36M 10-K · filed 2014-03-11 |
| 2011-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $2.52M derived: sum of 2 quarters · filed 2012-11-02 | $2.66M 10-Q · filed 2012-11-02 | $5.28M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.52M 10-Q · filed 2012-08-09 | $4.13M derived: sum of 3 quarters · filed 2013-03-12 | $4.93M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $141.08K 10-Q · filed 2012-05-04 | $2.76M derived: sum of 2 quarters · filed 2013-03-12 | $3.55M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $3.41M derived: sum of 2 quarters · filed 2013-03-12 | $3.87M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $794.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.26M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $462.81K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $3.97M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |